Pluripotency in the Embryo and in Culture

  1. Austin Smith1,3
  1. 1Wellcome Trust Centre for Stem Cell Research, Stem Cell Institute University of Cambridge, Cambridge CB2 1QR, United Kingdom
  2. 2Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 1QR, United Kingdom
  3. 3Department of Biochemistry, University of Cambridge, Cambridge CB2 1QR, United Kingdom
  1. Correspondence: ags39{at}cam.ac.uk

Abstract

Specific cells within the early mammalian embryo have the capacity to generate all somatic lineages plus the germline. This property of pluripotency is confined to the epiblast, a transient tissue that persists for only a few days. In vitro, however, pluripotency can be maintained indefinitely through derivation of stem cell lines. Pluripotent stem cells established from the newly formed epiblast are known as embryonic stem cells (ESCs), whereas those generated from later stages are called postimplantation epiblast stem cells (EpiSCs). These different classes of pluripotent stem cell have distinct culture requirements and gene expression programs, likely reflecting the dynamic development of the epiblast in the embryo. In this chapter we review current understanding of how the epiblast forms and relate this to the properties of derivative stem cells. We discuss whether ESCs and EpiSCs are true counterparts of different phases of epiblast development or are culture-generated phenomena. We also consider the proposition that early epiblast cells and ESCs may represent a naïve ground state without any prespecification of lineage choice, whereas later epiblasts and EpiSCs may be primed in favor of particular fates.



Also in this Collection

      | Table of Contents

      In this Collection